Adimmune (TPE:4142) Net Change in Cash : NT$-113 Mil (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Adimmune Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Adimmune's Net Change in Cash for the three months ended in Dec. 2024 was NT$544 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-113 Mil.

Adimmune Net Change in Cash Historical Data

The historical data trend for Adimmune's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adimmune Net Change in Cash Chart

Adimmune Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

3,033.56

-1,435.45

205.07

-399.58

-112.88

Adimmune Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															368.86	521.64	-781.25	-397.64	544.37

Adimmune Net Change in Cash Calculation

Adimmune's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	668.481	+	-310.899	+	-478.802	+	8.339
	=	-113

Adimmune's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 658.32 + -85.955 + -32.206 + 4.212

= 544

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-113 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adimmune Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Adimmune's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Adimmune Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adimmune Corp (TPE:4142) » Definitions » Net Change in Cash

Comparable Companies

TPE:6949 ROCO:4726 ROCO:4157 ROCO:7759 ROCO:6976 TPE:1760 ROCO:6875 ROCO:6586 TPE:6541 ROCO:4167 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX

Traded in Other Exchanges

N/A

Address

Tanxing Road, No. 3, Sector 1, Tanzi District, Taichung, TWN, 427003

Website

https://www.adimmune.com.tw

Adimmune Corp is a Taiwan-based company. It is engaged in the development, manufacture, and distribution of vaccines and other biological products. Its pipeline consists of products like AdimFlu-S (QIS) which is a vaccine intended for use in the prevention of influenza, and TetraFlu among others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the USA, China, and other regions.

Adimmune Headlines

No Headlines